Genomics Platform TenSixteen is building a precision platform around somatic mosaicism and CHIP to discover age-related disease therapeutics. This creates demand for scalable data integration, secure genomics data pipelines, and ML-powered analytics; propose partnerships to co-develop data workflows and validated biomarkers.

Cloud & Data With Google Cloud as the backbone, they likely need scalable cloud infrastructure, genomics data warehouses, reproducible ML pipelines, and robust data governance. Position cloud-native data platform services, MLOps, and HIPAA/GDPR-compliant security to accelerate development.

Growth & Partnerships A lean team with significant funding presents an opportunity for strategic business development: partner with CROs, pharma sponsors, and academia; propose alliance management, joint development agreements, and licensing strategies to scale discovery and clinical programs.

Market Positioning Being a first mover in CHIP-based therapeutics, TenSixteen has a differentiated story to attract collaborators; offer market access consulting, clinical development strategy, and proof-of-concept collaboration opportunities to accelerate adoption.

Digital Marketing Their web and marketing stack (Wix, WordPress, SEO tools) signals room to strengthen digital presence and lead generation for partnerships and investors; propose Martech integration, analytics, content marketing, and targeted outreach campaigns to generate high-quality opportunities.